Sodium-glucose co-transporter-2 inhibitors are a class of antihyperglycemic agents that can be used to improve glycemic control in the treatment of type 2 diabetes.
Amanda Daniels, PharmD
Advertisement
Articles by Amanda Daniels, PharmD
Advertisement
Latest Updated Articles
Sodium-Glucose Co-Transporter-2 Inhibitors: An Update on the Evidence for Treatment of Type 2 DiabetesPublished: October 13th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
3
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
4
Population Genomic Screening Improves Lipid Management in Familial Hypercholesterolemia
5
